Does Cognitive Status Affect Pulmonary Rehabilitation Gains?
1 other identifier
interventional
50
1 country
1
Brief Summary
Pulmonary rehabilitation program with aerobic and strengthening trainings for 3 months will be applied to the candidates for lung transplantation. The program will be designed to be 2 days supervised weekly and 3 day home program. After completion of the program, patients will be divided into two groups according to their cognitive status (Group 1: those with poor cognition; Group 2: those with good cognition). The PR gains of the groups will be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2018
CompletedStudy Start
First participant enrolled
November 13, 2018
CompletedFirst Posted
Study publicly available on registry
November 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMay 1, 2025
April 1, 2025
7.1 years
November 2, 2018
April 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from Baseline the 6 minutes walk distance at 3 months.
The test was conducted in a 30-m corridor in line with American Thoracic Society (ATS) guidelines. Patients were told that they should walk as fast as they can walk in 6 minutes time.
3 months
Change from Baseline the Montreal Cognitive Assessment (MoCA) test score at 3 months.
It was designed to detect mild cognitive impairment.Thirty items assessing multiple cognitive domains are contained in the MoCA: short-term memory (5 points); visuospatial abilities via clock drawing (3 points), and a cube copy task (1 point); executive functioning via an adaptation of Trail Making Test Part B (1 point), phonemic fluency (1 point), and verbal abstraction (2 points); attention, concentration, and working memory via target detection (1 point), serial subtraction (3 points), digits forward (1 point), and digits backward (1 point); language via confrontation naming with low-familiarity animals (3 points), and repetition of complex sentences (2 points); and orientation to time and place (6 points). The MoCA is scored by obtaining an item total and the authors recommend a clinical cutoff score of 23.
3 months
Secondary Outcomes (2)
Change from Baseline the modified Medical Council Dyspnea score at 3 months.
3 months
Change from Baseline the Forced Expiratory Volume in 1 second (FEV1) at 3 months.
3 months
Study Arms (2)
Group1
EXPERIMENTALThose with poor cognition (MOCA score\<23) The patients will receive the Pulmonary Rehabilitation program for 3-months (2 days at hospital, 3 days at home). Exercise program includes aerobic (walking band, bicycle, arm ergometer) and strengthening (with free weights) components.
Group2
EXPERIMENTALThose with good cognition (MOCA score≥23) The patients will receive the Pulmonary Rehabilitation program for 3-months (2 days at hospital, 3 days at home). Exercise program includes aerobic (walking band, bicycle, arm ergometer) and strengthening (with free weights) components.
Interventions
Exercise program includes aerobic (walking band, bicycle, arm ergometer) and strengthening (with free weights) components.
Eligibility Criteria
You may qualify if:
- To be listed for lung transplantation,
- Pulmonary rehabilitation exercise program planned to be taken,
- Volunteers who have agreed to participate in the work,
- Patients who can complete the 3-month Pulmonary Rehabilitation program.
You may not qualify if:
- Failure to complete the planned exercise program for any reason,
- Not to be literate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yedikule Chest Disease Hospital
Istanbul, Zeytinburnu, 34200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Esra Pehlivan, PhD
Saglik Bilimleri Universitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 2, 2018
First Posted
November 14, 2018
Study Start
November 13, 2018
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
May 1, 2025
Record last verified: 2025-04